17:I[66739,["/_next/static/chunks/0.3dg.jzl0xwf.js?dpl=dpl_3RxvMhdoqChZq1Vee41wPR23ae8V","/_next/static/chunks/0skdv12y78fnh.js?dpl=dpl_3RxvMhdoqChZq1Vee41wPR23ae8V","/_next/static/chunks/10dnvbzcepzg2.js?dpl=dpl_3RxvMhdoqChZq1Vee41wPR23ae8V","/_next/static/chunks/0w-9dtq49e_fk.js?dpl=dpl_3RxvMhdoqChZq1Vee41wPR23ae8V","/_next/static/chunks/1331nw5i_3lcb.js?dpl=dpl_3RxvMhdoqChZq1Vee41wPR23ae8V","/_next/static/chunks/053zyoym-_i67.js?dpl=dpl_3RxvMhdoqChZq1Vee41wPR23ae8V"],"default"] 19:I[38632,["/_next/static/chunks/0qqtp3r0h7kah.js?dpl=dpl_3RxvMhdoqChZq1Vee41wPR23ae8V","/_next/static/chunks/0iukvycbd42rl.js?dpl=dpl_3RxvMhdoqChZq1Vee41wPR23ae8V"],"IconMark"] 18:T4f3,

Harvey Lodish, a professor at the Massachusetts Institute of Technology (MIT) for almost 50 years, explains the significance of biotechnology in the medical world's future scenario. Prof. Lodish also gives his perspective on creating a supportive and lucrative academic atmosphere and science entrepreneurship—based on his experience mentoring two Nobel Prize Winners and starting eight biotech companies, respectively.

Prof. Lodish is the chair of the Board Research Committee: Boston Children's Hospital and the founding member of the Whitehead Institute for Biomedical Research. His expertise includes biomechanics, biomolecular engineering, macromolecular biochemistry, metabolism, genetics, to genomics. Some of his well-known companies are Genzyme Inc., Millennium Pharmaceuticals, and Rubius Therapeutics. #Endgame #GitaWirjawan #HarveyLodish

-----------------

Pre-Order the official Endgame merchandise:
https://wa.me/628119182045

SGPP Indonesia Master of Public Policy March 2023 Intake:
admissions.sgpp.ac.id
admissions@sgpp.ac.id
https://wa.me/628111522504

Other "Endgame" episode Playlist:
https://endgame.id/season2
https://endgame.id/season1
https://endgame.id/thetake

Harvey Lodish: Biotechnology - Humanity's Promising Future

Endgame with Gita Wirjawan

Harvey Lodish: Biotechnology - Humanity's Promising Future